Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 175
Summary
- Conditions
- Diabetes Mellitus - Type 2
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 64 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04524832
- Collaborators
- Not Provided
- Investigators
- Study Director: Clinical Reporting Anchor and Disclosure 1452 Novo Nordisk A/S